Suppr超能文献

阑尾杯状细胞类癌:来自腹膜肿瘤参考服务中心和欧洲神经内分泌肿瘤学会卓越中心的管理考量

Appendiceal Goblet Cell Carcinoids: Management Considerations from a Reference Peritoneal Tumour Service Centre and ENETS Centre of Excellence.

作者信息

Lamarca Angela, Nonaka Daisuke, Lopez Escola Cristina, Hubner Richard A, O'Dwyer Sarah, Chakrabarty Bipasha, Fulford Paul, Valle Juan W

出版信息

Neuroendocrinology. 2016;103(5):500-17. doi: 10.1159/000440725. Epub 2015 Sep 10.

Abstract

BACKGROUND

Appendix goblet cell carcinoids are known to share histological features of adenocarcinoma and neuroendocrine tumours. Due to their low incidence, quality evidence is lacking for the management of these patients.

METHODS

We performed a single-centre retrospective study of patients with a confirmed diagnosis of appendiceal goblet cell carcinoid (GCC; 1996-2014). Patients were divided into curative intent (CI) and palliative intent (PI) cohorts. Our primary end point was overall survival (OS).

RESULTS

Seventy-four patients were eligible; 76% were treated with CI [surgery only (36%), cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemotherapy (HIPEC; 36%), adjuvant chemotherapy (20%) and a combination of CRS and HIPEC followed by adjuvant chemotherapy (9%)], and 23% had advanced-stage disease amenable to palliative treatment (chemotherapy or supportive care) only. Completion right hemicolectomy, performed in 64% of the CI cohort, did not impact on the relapse rate or disease-free survival. FOLFOX chemotherapy was used in both the adjuvant and palliative settings; safety was as expected, and we observed a high rate (60%) of disease control in the palliative cohort. The estimated median OS (all patients), disease-free survival (CI patients) and progression-free survival (PI patients) were 52.1 (95% CI 29.4-90.3), 75.9 (26.6-not reached) and 5.3 (0.6-5.7) months, respectively. Age and stage were independent factors associated with OS in the multivariable analysis. Tang classification showed a trend for impact on OS. No benefit from specific adjuvant approach was identified; however, selection bias for treatment approach was observed.

CONCLUSION

Prospective trials are needed to define optimal approaches in GCC. All GCC patients should be managed by specialized centres due to their esoteric behaviour; we provide management considerations based on our experience and conclusions.

摘要

背景

已知阑尾杯状细胞类癌具有腺癌和神经内分泌肿瘤的组织学特征。由于其发病率低,缺乏针对这些患者管理的高质量证据。

方法

我们对确诊为阑尾杯状细胞类癌(GCC;1996 - 2014年)的患者进行了单中心回顾性研究。患者被分为根治性意图(CI)和姑息性意图(PI)队列。我们的主要终点是总生存期(OS)。

结果

74例患者符合条件;76%接受了根治性治疗[仅手术(36%)、细胞减灭术(CRS)和热灌注化疗(HIPEC;36%)、辅助化疗(20%)以及CRS联合HIPEC后辅助化疗(9%)],23%患有晚期疾病,仅适合姑息治疗(化疗或支持治疗)。CI队列中64%进行了右半结肠切除术,这对复发率或无病生存期没有影响。FOLFOX化疗用于辅助和姑息治疗;安全性符合预期,我们在姑息队列中观察到较高的疾病控制率(60%)。所有患者的估计中位总生存期、CI患者的无病生存期和PI患者的无进展生存期分别为52.1(95%CI 29.4 - 90.3)、75.9(26.6 - 未达到)和5.3(0.6 - 5.7)个月。在多变量分析中,年龄和分期是与总生存期相关的独立因素。Tang分类显示出对总生存期有影响的趋势。未发现特定辅助治疗方法的益处;然而,观察到治疗方法的选择偏倚。

结论

需要进行前瞻性试验来确定GCC的最佳治疗方法。由于其罕见的行为,所有GCC患者应由专业中心管理;我们根据经验和结论提供管理方面的考虑因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验